author-photo

Michelle Geddes

Tom Baker Cancer Centre
University of Calgary

66

Papers

901

Citations

Citation Trend

Filter By

Papers (43) Sort By

Journal Conference Others

Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Topic: AS02-Epidemiology

2021 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)
Fatigue, However Measured, Continues to Refine Prognosis in Higher Risk MDS: An MDS-CAN Study

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
High Transfusion Dependence and Serum Ferritin but Not Transferrin Saturation Predict Inferior Clinical Outcomes in Patients with MDS

2020 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Revised 15-item MDS-specific frailty scale maintains prognostic potential

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (3)
An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

2019 Leukemia
Show All
- Source
- Cite
- Save
Citations (12)
A retrospective, real-world population-based analysis of treatment patterns and outcomes in adult patients with relapsed/refractory acute myeloid leukemia in Alberta, Canada.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Intermittent Transfusion Independence Is Associated with Improved Overall Survival in Patients with Transfusion Dependent MDS

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Health Related Quality of Life Remains Stable over Time in Myelodysplastic Syndrome: An MDS-CAN Prospective Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS

2018 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (10)